INHIBITION OF GSK-3β IDENTIFIES IT AS A NOVEL THERAPEUTIC TARGET IN PANCREATIC CANCER.
Ougolkov, A.V., Billadeau, D.D.Volume:
29
Language:
english
Journal:
Pancreas
DOI:
10.1097/00006676-200411000-00128
Date:
November, 2004
File:
PDF, 580 KB
english, 2004